[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Senseonics Holdings Inc (SENS)

Senseonics Holdings Inc (SENS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 241,203
  • Shares Outstanding, K 41,803
  • Annual Sales, $ 35,260 K
  • Annual Income, $ -69,110 K
  • EBIT $ -87 M
  • EBITDA $ -85 M
  • 60-Month Beta 1.05
  • Price/Sales 6.90
  • Price/Cash Flow N/A
  • Price/Book 7.08

Options Overview Details

View History
  • Implied Volatility 78.47% (-6.74%)
  • Historical Volatility 99.43%
  • IV Percentile 2%
  • IV Rank 15.98%
  • IV High 200.52% on 10/10/25
  • IV Low 55.26% on 08/19/25
  • Expected Move (DTE 32) 1.06 (18.41%)
  • Put/Call Vol Ratio 3.19
  • Today's Volume 113
  • Volume Avg (30-Day) 319
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 8,956
  • Open Int (30-Day) 8,865
  • Expected Range 4.71 to 6.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.55
  • Number of Estimates 3
  • High Estimate $-0.54
  • Low Estimate $-0.56
  • Prior Year $-0.40
  • Growth Rate Est. (year over year) -37.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.79 +20.46%
on 05/05/26
7.45 -22.55%
on 04/28/26
-1.13 (-16.38%)
since 04/15/26
3-Month
4.79 +20.46%
on 05/05/26
8.57 -32.67%
on 02/25/26
-1.74 (-23.17%)
since 02/13/26
52-Week
4.79 +20.46%
on 05/05/26
12.58 -54.13%
on 07/17/25
-5.23 (-47.53%)
since 05/15/25

Most Recent Stories

More News
Senseonics Holdings, Inc. Common Stock Q1 Earnings Call Highlights

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) raised its full-year 2026 revenue outlook after reporting first-quarter growth tied to adoption of its Eversense 365 continuous glucose monitoring system...

SENS : 5.77 (-0.86%)
Senseonics: Q1 Earnings Snapshot

Senseonics: Q1 Earnings Snapshot

SENS : 5.77 (-0.86%)
Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results

Generated Q1 revenue of $11.7 million, an increase of 87% year-over-year Expect full-year revenue in the range of $60M - $64M (previously $58M to $62M) Strong strategic and commercial progress,...

SENS : 5.77 (-0.86%)
Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 

GERMANTOWN, Md., May 04, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the design, development and commercialization of long-term, implantable...

SENS : 5.77 (-0.86%)
Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million

GERMANTOWN, Md., May 04, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the design, development and commercialization of glucose monitoring...

SENS : 5.77 (-0.86%)
HTGC : 15.53 (+0.19%)
Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time

GERMANTOWN, Md., May 01, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable...

SENS : 5.77 (-0.86%)
Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term,...

SENS : 5.77 (-0.86%)
Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term,...

SENS : 5.77 (-0.86%)
Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System

The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks as part of a phased roll out Eversense 365 doubles sensor lifespan from...

SENS : 5.77 (-0.86%)
First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

New data shows positive real-world impact of the world’s first and only one-year CGM, with a full year of strong patient adherence, glucometrics and hypoglycemic outcomes Eversense 365 delivered...

SENS : 5.77 (-0.86%)

Business Summary

Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.

See More

Key Turning Points

3rd Resistance Point 6.12
2nd Resistance Point 5.99
1st Resistance Point 5.88
Last Price 5.77
1st Support Level 5.65
2nd Support Level 5.52
3rd Support Level 5.41

See More

52-Week High 12.58
Fibonacci 61.8% 9.60
Fibonacci 50% 8.68
Fibonacci 38.2% 7.77
Last Price 5.77
52-Week Low 4.79

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.